PFIZER
About
At Pfizer, the Associate Data Scientist is responsible to assist Pfizer’s Data Management staff to leverage both internal and external data assets to deliver business insights, implement automation and Artificial Intelligence (AI) methods by collaborating with cross-functional teams within the organization with an overall goal of enhancing tactical and strategic decision making.
Updates & Highlights
Study Results from Johns Hopkins University Bloomberg School of Public Health Provide New Insights into Managed Care and Specialty Pharmacy (Medicaid access to Most Favored Nation through the Pfizer agreement: The unanswered issues): Drugs and T
Study Results from Johns Hopkins University Bloomberg School of Public Health Provide New Insights into Managed Care ...
InsuranceNewsNet · 44 minutes ago
Top Analyst Reports for Meta, Pfizer & Salesforce
Top Analyst Reports for Meta, Pfizer & Salesforce
Yahoo Finance · about 2 hours ago
Pfizer Options Spot-On: On May 13th, 121.75K Contracts Were Traded, With 2.64 Million Open Interest
Pfizer Options Spot-On: On May 13th, 121.75K Contracts Were Traded, With 2.64 Million Open Interest
Moomoo · about 2 hours ago
Recent Openings
View all 4 jobsAI Engineer III
Θεσσαλονίκη, GRB, GR
AI Engineer III (ΑΙ Innovation)
Θεσσαλονίκη, GRB, GR
Staff AI Engineer
Θεσσαλονίκη, GRB, GR
Associate Data Scientist
Cambridge, MA, US
All Jobs
AI Engineer III
Θεσσαλονίκη, GRB, GR
AI Engineer III (ΑΙ Innovation)
Θεσσαλονίκη, GRB, GR
Staff AI Engineer
Θεσσαλονίκη, GRB, GR
Associate Data Scientist
Cambridge, MA, US
Culture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
Parental Leave
Family-friendly policies
401(k) Match
Retirement savings
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Pfizer?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company →News & Press
20 recentStudy Results from Johns Hopkins University Bloomberg School of Public Health Provide New Insights into Managed Care and Specialty Pharmacy (Medicaid access to Most Favored Nation through the Pfizer agreement: The unanswered issues): Drugs and T
Study Results from Johns Hopkins University Bloomberg School of Public Health Provide New Insights into Managed Care and Specialty Pharmacy (Medicaid access to Most Favored Nation through the Pfizer agreement: The una...
InsuranceNewsNet · 44 minutes ago
Top Analyst Reports for Meta, Pfizer & Salesforce
Top Analyst Reports for Meta, Pfizer & Salesforce
Yahoo Finance · about 2 hours ago
Pfizer Options Spot-On: On May 13th, 121.75K Contracts Were Traded, With 2.64 Million Open Interest
Pfizer Options Spot-On: On May 13th, 121.75K Contracts Were Traded, With 2.64 Million Open Interest
Moomoo · about 2 hours ago
Pfizer’s Hympavzi Indication Expanded in EU for Treatment of Hemophilia A or B With Inhibitors
Pfizer’s Hympavzi Indication Expanded in EU for Treatment of Hemophilia A or B With Inhibitors
Contract Pharma · about 4 hours ago
Rigel Pharmaceuticals Enters an Exclusive Global Licensing Agreement with Arvinas and Pfizer for Veppanu | PharmExec
Rigel Pharmaceuticals Enters an Exclusive Global Licensing Agreement with Arvinas and Pfizer for Veppanu | PharmExec
Pharmaceutical Executive · about 5 hours ago
Can Pfizer Achieve High Single-Digit Revenue CAGR From 2029?
Can Pfizer Achieve High Single-Digit Revenue CAGR From 2029?
Yahoo Finance · about 8 hours ago
EC approves added indication for Pfizer’s Hympavzi
EC approves added indication for Pfizer’s Hympavzi
The Pharma Letter · about 8 hours ago
Pfizer wins Hympavzi label expansion in Europe (PFE:NYSE)
Pfizer wins Hympavzi label expansion in Europe (PFE:NYSE)
Seeking Alpha · about 11 hours ago
European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors
European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors
Business Wire · about 13 hours ago
Pfizer Shifts VEPPANU Rights To Rigel As Valuation Gap Persists
Pfizer Shifts VEPPANU Rights To Rigel As Valuation Gap Persists
Yahoo Finance · about 15 hours ago
Darren Back: Pfizer’s ‘Give Forward’ Program Embodies the Spirit of Service Across U.S. and Puerto Rico
Darren Back: Pfizer’s ‘Give Forward’ Program Embodies the Spirit of Service Across U.S. and Puerto Rico
Oncodaily · about 16 hours ago
Pfizer (PFE) Delivered a Solid Q1. The Patent Cliff Keeps Me Bearish
Pfizer (PFE) Delivered a Solid Q1. The Patent Cliff Keeps Me Bearish
TipRanks · about 18 hours ago
Pfizer: Don't Pass On This Dirt-Cheap Buying Opportunity. (NYSE:PFE)
Pfizer: Don't Pass On This Dirt-Cheap Buying Opportunity. (NYSE:PFE)
Seeking Alpha · 1 day ago
Prediction: Pfizer Will Beat the Market Over the Next 5 Years
Prediction: Pfizer Will Beat the Market Over the Next 5 Years
The Motley Fool · 1 day ago
Pfizer’s New San Diego R&D Hub Accelerates the Next Wave of Cancer Innovation
Pfizer’s New San Diego R&D Hub Accelerates the Next Wave of Cancer Innovation
Pfizer · 1 day ago
Arvinas, Pfizer find new partner for ‘Protac’ breast cancer drug
Arvinas, Pfizer find new partner for ‘Protac’ breast cancer drug
BioPharma Dive · 1 day ago
Pfizer, Arvinas win $85M upfront in Rigel licensing pact for new breast cancer med Veppanu
Pfizer, Arvinas win $85M upfront in Rigel licensing pact for new breast cancer med Veppanu
Fierce Pharma · 1 day ago
Pfizer and Arvinas give disappointing breast cancer drug to Rigel
Pfizer and Arvinas give disappointing breast cancer drug to Rigel
Endpoints News · 1 day ago
BridgeBio’s Attruby challenges Pfizer’s Vyndamax legacy in pivotal ATTR trial
BridgeBio’s Attruby challenges Pfizer’s Vyndamax legacy in pivotal ATTR trial
Clinical Trials Arena · 1 day ago
Rigel strikes licensing deal for Pfizer and Arvinas' breast cancer drug
Rigel strikes licensing deal for Pfizer and Arvinas' breast cancer drug
Reuters · 1 day ago